Can Propylene Glycol Cause a High Anion Gap?
What propylene glycol exposure is and where it is found
Propylene glycol is a dissolving agent and delivery agent used in a range of medical and nonmedical products. In clinical settings, it is most important because it can appear in IV medications, especially certain sedatives and other formulations that need a liquid base. It can also be included in some oral products and topical products. Most exposures are harmless, but large or prolonged exposure can create a toxicity problem, especially in hospitalized patients.
This matters because propylene glycol is not just an ingredient; it is a compound that is metabolized by the body into other substances. Under the right conditions, those metabolites can affect acid-base balance and lead to abnormal serum chemistry findings. In some patients, the clinical picture includes high anion gap findings, especially when the exposure is significant or renal clearance is impaired.
From a diagnostic workup standpoint, propylene glycol exposure is often overlooked unless the medication list is reviewed closely. That is why laboratory interpretation must be paired with clinical correlation. The product source, route of exposure, and duration all influence whether propylene glycol becomes clinically relevant.
How the anion gap is determined
The anion gap is a calculated value used to assist in identifying certain patterns of metabolic acidosis. It represents the difference between tested cations and observed anions in the blood. The most common anion gap formula uses serum sodium, serum chloride, and serum bicarbonate.
A basic version is:
An anion gap calculator performs this computation and can assist clinicians and patients see whether the result sits in a normal span or indicates an acid-base disorder. Because the result depends on the measured electrolyte values, even small electrolyte abnormalities can change the number.
The anion gap is useful because unmeasured anions can accumulate in the blood during conditions such as lactic acidosis, ketoacidosis, or toxin ingestion. When interpreting the number, clinicians also consider albumin, since low albumin can decrease the measured gap and obscure a clinically important issue. That is why the albumin-corrected anion gap is often more revealing than the unadjusted value.
What makes propylene glycol can raise the anion gap
Indeed, propylene glycol can result in a high anion gap in the setting of propylene glycol toxicity. The mechanism is usually secondary rather than sudden. After exposure, propylene glycol is converted into acidic compounds, including organic acids, which can contribute to high anion gap metabolic acidosis. In addition, the body may develop a coexisting lactic acidosis, which additionally increases the gap.
Another important clue is the osmolar gap. Propylene glycol itself elevates serum osmolarity, so early toxicity may present with an elevated osmolar gap before the anion gap rises. As metabolism advances, the parent compound decreases while acidic metabolites collect, shifting the pattern from isolated osmolar gap elevation to a combined osmolar gap and high anion gap picture.
This progression is why the moment of testing matters. A patient may initially have a high osmolar gap and later show progressive acidosis, elevated lactate, and a rising anion gap. In other words, propylene glycol can be part of a combined laboratory pattern that develops over time.
Typical causes of increased anion gap metabolic acidosis
Propylene glycol is just one potential cause of metabolic acidosis. A comprehensive differential diagnosis is essential whenever the anion gap is elevated. Common causes include ketoacidosis, lactic acidosis, renal failure, and ingestion of toxic alcohols. All of these can produce a similar lab pattern, but the underlying mechanism is different.
Ketoacidosis is often seen with diabetes, starvation, or prolonged vomiting, while lactic acidosis may occur with shock, sepsis, hypoperfusion, or certain drugs and toxins. Renal failure can raise the gap because the kidneys cannot clear acid effectively, allowing unmeasured acids to accumulate. Toxic alcohols, such as methanol or ethylene glycol, can also create an elevated anion gap and osmolar gap pattern.
For this reason laboratory interpretation should not rely on a single number alone. The anion gap calculator can identify a abnormal result, but the final diagnosis depends on the clinical context, medication exposure, and additional testing.
Indicators and symptoms of propylene glycol toxicity
The clinical signs of propylene glycol toxicity can be unclear at first. Patients may experience altered mental status, hypotension, and tachypnea as the acid-base disturbance worsens. Tachypnea often suggests respiratory compensation for acidosis. Some patients may also display signs of poor perfusion or sedation, depending on the overall exposure and the medications involved.
A rising serum lactate can be an key clue, especially when the clinical picture suggests an unclear acid-base disturbance. Elevated lactate does not establish propylene glycol as the cause, but it increases suspicion when combined with medication exposure, abnormal serum chemistry, and a high anion gap. Because the symptoms overlap with other illnesses, clinical correlation is critical.
Severe cases can deteriorate fast, particularly when the patient has reduced clearance or multiple risk factors. A careful review of medications, infusion history, and serial labs is often the quickest way to recognize the problem.
Lab tests used to evaluate suspected toxicity
When propylene glycol contact is suspected, the workup usually includes serum osmolality, calculation of the osmolar gap, a blood gas, and evaluation of renal function. These measures help determine whether the patient has a blended toxic-metabolic presentation.
Serum osmolality is compared with the calculated osmolarity to identify an osmolar gap. A widened gap suggests unmeasured osmotically active substances, which may include propylene glycol or other toxic alcohols. The blood gas helps define the severity of the acid-base disorder and shows whether the patient has metabolic acidosis with respiratory compensation. Renal function testing is important because reduced clearance can worsen toxicity and prolong exposure.
Further laboratory tests often include serum lactate, electrolytes, and repeat chemistry panels. Serial testing can show whether the anion gap is rising or resolving after intervention. In many patients, the pattern of serum chemistry abnormalities provides the strongest evidence before specialized toxin levels are available.
How to understand an Anion Gap Calculator output
An anion gap calculator is useful, but the finding should always be interpreted in relation. First, confirm whether the value is in the normal range for the laboratory used. Normal ranges can differ a bit depending on the analyzer and whether potassium is included in the formula. A value that is borderline in one lab may be obviously abnormal in another.
Next, evaluate the possibility of hypoalbuminemia. Because albumin is a major unmeasured anion, low albumin can mask a true acidosis. An albumin-corrected anion gap gives a better estimate of the underlying acid burden when albumin is reduced. This adjustment is most useful in critically ill patients, where albumin is often low.
Lastly, ask whether the result fits the overall picture. A high anion gap with normal lactate and normal ketones may point toward a toxin, while a high gap with elevated lactate may indicate tissue hypoperfusion, sepsis, or propylene glycol toxicity. Good interpretation depends on clinical context, not just the number.
When propylene glycol exposure turns dangerous
The risk rises with dose-related toxicity, prolonged exposure, and decreased ability to remove the compound. This is particularly important with some benzodiazepines and other intravenous medications that include propylene glycol as a solvent. Continuous, high-dose infusion can result in accumulation over time.
Renal impairment adds risk because the kidneys have a key role in clearing the compound and its byproducts. If renal clearance is reduced, propylene glycol and its metabolites may build up, leading to osmolar gap elevation, lactic acidosis, and high anion gap metabolic acidosis.
The risk is greatest when multiple factors stack together: high medication dose, prolonged infusion, critical illness, dehydration, and impaired kidney function. In that setting, delta ratio mixed acid base guide monitoring should be more regular and clinicians should stay highly alert for toxicity.
Treatment and management of suspected propylene glycol toxicity
The first step in management is discontinuation of the suspected source. Discontinuing the offending medication or exposure can avoid more accumulation. Depending on the severity of the case, the patient may also need supportive care, including fluid resuscitation, correction of electrolyte abnormalities, and treatment of acidosis.
Monitoring is crucial after the exposure is stopped. Serial serum chemistry testing, blood gas assessment, serum lactate, and renal function checks help show whether the acid-base disorder is getting better. If the patient has severe symptoms, rapidly worsening acidosis, or significant renal dysfunction, more aggressive treatment may be needed.
Hemodialysis can be considered in severe cases because it helps remove propylene glycol and correct associated metabolic derangements. It may be especially useful when there is significant acidosis, hemodynamic instability, or impaired renal clearance. The decision is based on the full clinical picture rather than the anion gap alone.
When to require immediate medical evaluation
Urgent evaluation is needed if there are emergency symptoms such as increasing confusion, profound weakness, breathing difficulty, collapse, or evidence of shock. A patient with suspected toxic exposure and a rapidly changing condition should not wait for scheduled review.
Worrisome findings include severe acidosis, very low bicarbonate, sustained hypotension, or quickly rising lactate. These findings may signal a serious acid-base disorder that needs urgent treatment. If propylene glycol exposure is possible, a prompt medical assessment can identify whether the patient needs hospital monitoring, medication changes, or hemodialysis.
As the disorder can overlap with other causes of high anion gap metabolic acidosis, clinicians should evaluate the whole picture early. Prompt review of medication exposure, serum osmolality, blood gas results, and renal function can prevent delays in care.
Frequently asked questions about propylene glycol and the anion gap
Can propylene glycol cause a high anion gap?
Yes, it can. Propylene glycol can cause a high anion gap, especially when exposure is marked or prolonged. It may first raise the osmolar gap and then, as it is metabolized into acidic metabolites, contribute to high anion gap metabolic acidosis and lactic acidosis.
What is the difference between an anion gap and an osmolar gap?
The anion gap shows unmeasured charged particles and helps recognize causes of metabolic acidosis. The osmolar gap shows the difference between measured and calculated osmolarity and suggests unmeasured dissolved substances, such as propylene glycol or other toxic alcohols. Both are helpful, but they serve different questions.
Which medications contain propylene glycol?
Propylene glycol can be found in some intravenous medications, including certain benzodiazepines, sedatives, and other formulations that use it as a solvent. It may also appear in some oral products and topical products. The exact formulation depends on the drug and manufacturer, so the medication list should be checked carefully.
What indications may indicate propylene glycol toxicity?
Possible symptoms include altered mental status, low blood pressure, increased respiratory rate, and signs of progressive acidosis. A elevated serum lactate may also be seen. As these findings are nonspecific, they must be assessed with history of exposure, lab results, and total clinical correlation.
How is propylene glycol toxicity treated?
Therapy usually starts with discontinuation of the source and supportive care. Clinicians observe the patient closely with repeat labs, including blood gas, serum chemistry, and renal function. In severe cases, hemodialysis may be used to eliminate the toxin and improve severe acidosis.